Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8 Q2 Revenues Decline by More Than Half As Net Loss Widens

NEW YORK, March 14 (GenomeWeb News) - Accelr8 today reported second-quarter sales of $40,490, less than half the $89,196 in revenues for the same period a year ago.


The company said its net loss for the three months ended Jan. 31 deepened to $849,726, or $.08 per share, versus a net loss of $359,527, or $.03 a year ago.


The company's fiscal year ends July 31.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.